Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05599490 · ClinicalTrials.gov registry record · NA
Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB
A NA study of Age-related Cognitive Decline, sponsored by Posit Science Corporation.
- Completed
- Registry status
- NA
- Development phase
- 135
- Enrollment target
- 2
- Study locations
NCT05599490: Completed NA study of Age-related Cognitive Decline, sponsored by Posit Science Corporation.
NCT05599490 is a NA study of Age-related Cognitive Decline that has completed, run by Posit Science Corporation. The registered enrollment target is 135 participants, below the 1,120-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (88% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05599490, a NA study of Age-related Cognitive Decline, has completed, sponsored by Posit Science Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 135 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study aims to examine the longer-term benefits of a novel, neuroplasticity-based, computerized and web-deliverable training program (PACR-CT) five years from the initial 10 weeks of training from our Phase II study - Protocol #: PSC-0605-17 (Aim 1) and test the interactive effect of previous training and 10 weeks of booster training (Aim 2). Both the study and the software being investigated meet the criteria of Non-Significant Risk.
Primary Outcome
Change in performance on global cognitive composite score based on the average of all normalized assessment measures.
Conditions Studied
Interventions
- OTHER Computerized Plasticity-Based Adaptive Cognitive Training
Study Locations (2)
Iowa
- University of Iowa - Iowa City
Texas
- University of Texas at Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2023-12-14 |
| Est. Completion | 2026-01-28 |
| Phase | NA |
What the finished NCT05599490 record still lists
NCT05599490 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, below the 1,120-participant average among 10 other Age-related Cognitive Decline trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Age-related Cognitive Decline appearing as the primary indexed condition, and to 1 intervention - of which Computerized Plasticity-Based Adaptive Cognitive Training is the first listed.
NCT05599490 reports a single indexed study location in Iowa, Texas.
Frequently Asked Questions
What is clinical trial NCT05599490 about?
NCT05599490 is a clinical study titled "Brain Enhancement Training Towards Elders Resilience to Aging, Phase IIB". This study aims to examine the longer-term benefits of a novel, neuroplasticity-based, computerized and web-deliverable training program (PACR-CT) five years from the initial 10 weeks of training from our Phase II study - Protocol #: PSC-0605-17 (Aim 1) and test the interactive effect of previous tr...
What is the current status of trial NCT05599490?
This trial is currently completed. It is a NA study. The enrollment target is 135 participants. The study started on 2023-12-14. Estimated completion is 2026-01-28.
What conditions does trial NCT05599490 study?
This clinical trial studies the following conditions: Age-related Cognitive Decline.
What interventions are being tested in trial NCT05599490?
The interventions under investigation include: Computerized Plasticity-Based Adaptive Cognitive Training (OTHER).
Who is sponsoring clinical trial NCT05599490?
This trial is sponsored by Posit Science Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05599490 being conducted?
This trial has 2 study locations across Iowa, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Age-related Cognitive Decline
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05599490's enrollment target sits among peer trials
135 5th of 10 higher than 6 of 10 other Age-related Cognitive Decline trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Age-related Cognitive Decline trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Feasibility and Adherence to a Technology-assisted Home-based Strength Training Program in Adults With Type 2 Diabetes Mellitus and Mild Cognitive Impairment
RECRUITING · NA
-
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
RECRUITING · NA
-
Cardiac-Control Affecting Learning Through Mindfulness (CALM)
RECRUITING · NA
-
Cognitive Multi-Tasking Training in Healthy Older Adults
COMPLETED · NA
-
Attention Training for Learning Enhancement and Resilience Trial
COMPLETED · NA
-
Effects of Tart Cherry Juice on the Body
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI